DE
Journey Medical Corporation
DERM · NASDAQ
$7.36 -0.41% (-$0.03)
1M +13.93%
Market Cap $195.1M
P/E Ratio -
Div. Yield -
ROE 20.23%
Piotroski F-Score Moderate
4/9Valuation
19 /100
Expensive EV/EBITDA 105.48x
P/S 2.86x
P/B 6.08x
Growth
22 /100
Declining Rev. growth 5.66%
Book val. growth 23.32%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 62.24%
Net margin 8.95%
Op. margin 4.41%
Quality
9 /100
Poor ROIC 5.23%
ROE 20.23%
ROA 6.21%
Debt
66 /100
Moderate Debt/Equity 0.80x
Current ratio 1.59x
Int. coverage -0.66x
Stability
35 /100
Moderate Beta 1.10x
Rev. volatility 21.95%
EPS volatility 177.50%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre DERM
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Claude Maraoui
Employees
58
Headquarters
Scottsdale
Evenimente viitoare
11 NOV.
Earnings
Upcoming earnings report